跳至主要内容
临床试验/JPRN-UMIN000014903
JPRN-UMIN000014903已完成1 期

A pilot feasibility and safety study of autologous umbilical cord blood cell therapy in infants with neonatal encephalopathy - Autologous cord blood cell therapy for neonatal encephalopathy

eonatal Encephalopathy Consortium, Japan0 个研究点目标入组 6 人开始时间: 2014年8月26日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 1days-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Known major congenital anomalies, such as chromosomal anomalies, heart diseases 2) Major intracranial hemorrhage identified by brain ultrasonography or computed tomography 3) Severe growth restriction, with birth-weight less than 1800 g 4) Severe infectious disease, such as sepsis 5) Hyperkalemia 6) Outborn infants (Infants born at hospitals other than the study sites) 7) Volume of collected cord blood <40 ml 8) Infants judged critically ill and unlikely to benefit from neonatal intensive care by the attending neonatologist

研究者

发起方
eonatal Encephalopathy Consortium, Japan

相似试验